DeepIntent, the leading healthcare advertising technology firm designed to influence improved patient health and business results, accomplished a key milestone, attaining growth for the fifth straight year and a triple-digit growth rate across CTV campaigns.
The firm added more than 100 employees in 2022, outpacing the expansion of the healthcare advertising industry as a whole, as pharmaceutical marketers increasingly embraced digital advertising, notably on CTV. In 2022, CTV spending on DeepIntent's demand-side platform grew by a factor of three, making it one of the fastest-growing channels for most pharmaceutical companies using the DeepIntent Healthcare Advertising Platform.
In the last year, DeepIntent has released several innovations that blend data and technology to increase the efficacy of campaigns. For example, using the patented technology of DeepIntent OutcomesTM, DeepIntent became the first demand-side platform to provide a patient reach guarantee in May of last year.
Founder and CEO of DeepIntent, Chris Paquette, said, "As we enter our seventh year as a company, DeepIntent has become more than the DSP of choice for healthcare marketers. Building upon our capabilities for campaign planning, activation, measurement, and optimization, we've made a number of strategic investments to keep that momentum going as we continue to lead pharma into the future."
(Source: Cision PR Newswire)
Additional achievements of DeepIntent in 2022 include the following:
Employing its first Chief Operating Officer, Amit Chaturvedi, who expanded revenues by more than tenfold at WarnerMedia, to integrate and grow DeepIntent's sales, client success, campaign management, and business development teams
Hosting a first-of-its-kind summit, "Innovating with Intent," on the future of CTV for healthcare marketers
Integration with LG Ads Solutions' real-time ACR data store covers over 30 million LG smart TVs in the US.
Winning multiple awards from PM360, which named Chris Paquette CEO of the Year and DeepIntent's Audience Marketplace one of the most innovative products of 2022.
leads the healthcare advertising business with data-driven, future-proof solutions. DeepIntent's technology, designed specifically for healthcare marketers, is proven to increase audience quality and script performance. Marketers can plan, monitor, activate, and optimize campaigns from a single platform. The company, conceived by former Memorial Sloan Kettering data scientists, enables nine of the top ten pharmaceutical companies and primary healthcare advertising agencies to enhance patient outcomes via the innovative use of advertising, data science, and real-world health data.